Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2026-01-23 @ 2:43 PM
Study NCT ID:
NCT05170256
Status:
UNKNOWN
Last Update Posted:
2022-08-12
First Post:
2021-11-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trastuzumab and Standard Treatment With Chemo- and Immunotherapy as First Line Treatment for HER2 Positive Esophageal Squamous Cell Carcinoma Patients
Sponsor:
Morten Mau-Sørensen
Organization: